Avricore Health Inc. (AVCR.V)
TSXV · CAD · Healthcare · Diagnostics & Research
CA$0.045 (-10.00%) as of
Key statistics
- Market cap
- 5.69M
- EPS (TTM)
- -0.0100
- Dividend yield
- 0.00%
- 52-week range
- 0.0450 – 0.1000
- Beta
- 0.40
- Revenue (TTM)
- 193.04k
- Profit margin
- 0.00%
- Volume
- 57.00k
About Avricore Health Inc.
Avricore Health Inc. engages in the health data and point-of-care technologies businesses in Canada and the United Kingdom. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Vancouver, BC, Canada
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.